Vanflyta

Active Ingredient(s): Quizartinib
FDA Approved: * July 20, 2023
Pharm Company: * DAIICHI SANKYO
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Vanflyta 17.7 mg Oral Tablet, Film Coated
NDC: 65597-504
Labeler:
Daiichi Sankyo Inc.
Vanflyta 26.5 mg Oral Tablet, Film Coated
NDC: 65597-511
Labeler:
Daiichi Sankyo Inc.